Contraindications Based on mechanisms and theoretical considerations, BPC-157 may not be appropriate for: Individuals with active cancer Pregnant or breastfeeding women Those with uncontrolled cardiovascular conditions People taking anticoagulant medications (effects on bleeding unknown) Individuals with autoimmune conditions (immune modulation effects unclear) Quality and Purity Concerns Perhaps the most significant safety concern involves product quality
Cao Y, Zhen S, Taylor AW, Appleton S, Atlantis E, Shi Z
This article breaks down what the research shows for GLP-1s, GH secretagogues, and BPC-157, who carries elevated risk, and the screening every patient should complete before starting a protocol
As noted by Dai et al
Zahra T, Butt SA, Arshad, M